NCT04781426View on ClinicalTrials.gov

PrEP Among MSM and TG in Myanmar

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
HIV Infections
Interventions
DRUG

Tenofovir Disoproxil Fumarate (TDF) 300 mg

PrEP regimens of Tenofovir Disoproxil Fumarate (TDF) 300 mg/Lamivudine (3TC) 300mg per oral (PO) daily

Trial Locations (1)

Unknown

Medical Action Myanmar Clinics, Yangon

Sponsors

Collaborators (1)

Medical Action Myanmar
All Listed Sponsors
collaborator

Medical Action Myanmar

OTHER

collaborator

Institute of Tropical Medicine, Belgium

OTHER

lead

Myanmar Oxford Clinical Research Unit

OTHER